High-titer neutralization of Mu and C.1.2 SARS-CoV-2 variants by vaccine-elicited antibodies of previously infected individuals
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Article activity feed
-
-
SciScore for 10.1101/2021.10.19.463727: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics Consent: The clinical study was conducted at the NYU Vaccine Center with participant’s written consent under IRB-approved protocols (18-02035 and 18-02037). Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Immunoblot analysis: Proteins were analyzed on immunoblots probed with mouse anti-spike monoclonal antibody (1A9) (GeneTex) anti-spikesuggested: (Imported from the IEDB Cat# 1A9, RRID:AB_2848025), anti-p24 monoclonal antibody (AG3.0) and anti-GAPDH monoclonal antibody (Life Technologies) followed by goat anti-mouse HRP-conjugated secondary … SciScore for 10.1101/2021.10.19.463727: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics Consent: The clinical study was conducted at the NYU Vaccine Center with participant’s written consent under IRB-approved protocols (18-02035 and 18-02037). Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Immunoblot analysis: Proteins were analyzed on immunoblots probed with mouse anti-spike monoclonal antibody (1A9) (GeneTex) anti-spikesuggested: (Imported from the IEDB Cat# 1A9, RRID:AB_2848025), anti-p24 monoclonal antibody (AG3.0) and anti-GAPDH monoclonal antibody (Life Technologies) followed by goat anti-mouse HRP-conjugated secondary antibody (Sigma). anti-p24suggested: Noneanti-p24 monoclonal antibody (AG3.0)suggested: Noneanti-GAPDHsuggested: Noneanti-GAPDH monoclonal antibody (Life Technologies) followed by goat anti-mouse HRP-conjugated secondary antibody (Sigma)suggested: NoneExperimental Models: Cell Lines Sentences Resources Binding assay: 293T cells were transfected with mutated spike variant expression vectors using lipofectamine 2000 and seeded in a 96-well plate at 1 × 104 / well. 293Tsuggested: NoneNeutralization assay by soluble ACE2: Briefly, pseudotyped virus was incubated with serially diluted recombinant soluble ACE2 protein for 1 hour at room temperature and subsequently added to 1 × 104 ACE2.293T cells. ACE2.293Tsuggested: NoneRecombinant DNA Sentences Resources The luminescence signal was read in an Envision 2103 microplate luminometer. α-complementation assay: 293T (4 × 106) were cotransfected with pcΔ19S and 5 μg pSCTZ-alpha N85 or variable amounts of pLenti.ACE2-HA and 5 μg of pSCTZ-omega by lipofection with lipofectamine 2000 (Invitrogen). pLenti.ACE2-HAsuggested: NonepSCTZ-omegasuggested: NoneSoftware and Algorithms Sentences Resources Statistical Analysis: All experiments were performed in technical duplicates or triplicates and the data were analyzed using GraphPad Prism 8. GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-